Ethico-legal issues in biomedicine patenting: a patent professional viewpoint.
Over the last two decades, the ethical implications of patents for biological materials and processes have been the subject of spirited public debate between the many individuals and groups on which the patent system impacts. Whereas copyright, trade marks, and other species of Intellectual Property Rights (IPR) are widely acceptable, the patent system evokes criticism from many quarters, especially in relation to the legal protection of inventions in the Life Sciences. Some of these criticisms expressed by prestigious public organisations are addressed here from the patent professional standpoint.
Crespi
R Stephen
RS
crespi@f2s.com
D001709:Biotechnology / Q000941:ethics* / Q000331:legislation & jurisprudence*; D033041:Embryo Research / Q000941:ethics / Q000331:legislation & jurisprudence; D005060:Europe; D005796:Genes; D006801:Humans; D018973:Intellectual Property; D010330:Patents as Topic / Q000941:ethics* / Q000331:legislation & jurisprudence*; D013234:Stem Cells
Nature. 2002 Feb 7;415(6872):577-9
11832913
Sci Eng Ethics. 2001 Jan;7(1):29-62
11214383
Sci Eng Ethics. 2001 Jan;7(1):3-6
11214384
Rev Derecho Genoma Hum. 2002 Jan-Jun;(16):266-71
12379991
Sci Eng Ethics. 2000 Apr;6(2):157-80
11273445
Science. 1998 May 1;280(5364):698-701
9563938